First To Know Pregnancy Test - Clinical Evaluation Protocol
First To Know Pregnancy Test Clinical Evaluation Protocol
NOWDiagnostics, Inc.
1,705 participants
Oct 14, 2025
OBSERVATIONAL
Conditions
Summary
This study is evaluating the ADEXUSDx® hCG CLIA moderately complex, FDA-cleared test for potential over the counter (OTC) use and marketing as the First To Know® (FTK) Pregnancy test. The investigational FTK Pregnancy test will be used to assess its clinical performance in the intended use population (i.e., lay users) through self-testing in a simulated home setting.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
For this observational trial , the Intervention of interest is the First To Know Pregnancy Test
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07304531